International Stem Cell (ISCO) Inventory Average (2011 - 2026)

International Stem Cell (ISCO) has reported Inventory Average for 16 consecutive years, with $1.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory Average rose 13.92% year-over-year to $1.6 million in Q2 2026; TTM through Jun 2026 was $1.6 million, a 13.92% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 10.41% from the prior year.
• Inventory Average was $1.6 million for Q2 2026 at International Stem Cell, up from $1.6 million in the prior quarter.
• Over five years, Inventory Average peaked at $1.6 million in Q2 2026 and troughed at $1.2 million in Q1 2025.
• A 5-year average of $1.4 million and a median of $1.3 million in 2022 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average gained 27.08% in 2022 and slipped 7.82% in 2023, its largest moves.
• Over 5 years, Inventory Average stood at $1.4 million in 2022, then fell by 7.82% to $1.3 million in 2023, then retreated by 1.82% to $1.3 million in 2024, then grew by 22.58% to $1.6 million in 2025, then gained by 3.03% to $1.6 million in 2026.
• The last three Inventory Average figures came in at $1.6 million (Q2 2026), $1.6 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.